Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 1 of 6 financial statements was filed late (for 2021, 39 days late).
- 2025not filed
- 202428/05/2025
- 202320/06/2024
- 202203/07/2023
- 202123/08/2022
- 202015/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Authorized Representatives
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 20 | $270.12 | 20% | |
| 56 | $756.35 | 56% | |
| 24 | $324.15 | 24% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2016-01-01 to 2025-01-14.
Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $30,355.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 5, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Torunia | |
| Sep 19, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,604$2,604 | Toruńska Agencja Rozwoju Regionalnego S.A. | |
| Sep 26, 2017 | Aid for SMEs for innovation support | $25,145$25,145 | MARSZAŁEK KUJAWSKO-POMORSKI |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2016-12-01 | Provision of specialist advisory services supporting the commercialisation of research and development results of Pharm 3000 Sp. z o.o. in the development of innovative, personalised dietary supplementation and health prevention based on diagnostic services and education | $25,358$25,358 | Regional Operational Programme of the Kujawsko-Pomorskie Voivodeship for 2014–2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DR Andresp. z o.o. | $453,987.42 | drandre.pl | ||
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-07-02 | Business resumed | |
| 2024-07-01 | Business suspended | |
| 2017-05-16 | Name change (Gnosigis → Pharm 3000) | |
| 2017-05-16 | PKD change (Removed: 8 codes; Added: 8 codes) | |
| 2015-11-20 | Entered in the register |
FAQ
Last updated: 2026-07-02